![]() Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | ![]() Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases. | ![]() Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 2009 | Founding Date 2009 | Founding Date 1999 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 185% decrease | Employees 6 | Employees 180 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 18.3 m | Valuation ($) 280.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €6.6m (FY, 2024) | Revenue (est.) €65.4m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €2.8m (FY, 2024) | Cost of goods €302k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.8m (FY, 2024) | Gross profit €70.8m (FY, 2025) |
Net income | Net income N/A | Net income (€18.3m) (FY, 2024) | Net income (€86m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 146m | Total funding raised $ 33.8m | Total funding raised N/A |

Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases.
View company
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company